MDS Virtual Congress 2020 » Parkinson's Disease: Cognitive functions

Alexithymia, Depression, and Cognition in Patients with Parkinson’s disease

G. Kenangil, M. Demir, E. Tur, F. Domaç (Istanbul, Turkey)

Anticholinergic Use in Parkinson’s Disease: Practice Patterns in Patients with Cognitive Impairment

N. Shetty, O. Dubaz, Y. Yu, H. Gao, T. Simuni (Chicago, IL, USA)

Anxiety disorders are associated with verbal memory impairment in Parkinson’s disease

N. Dissanayaka, E. Forbes, J. Yang, J. O'Sullivan, D. Copland, K. McMahon, L. Mitchell, G. Byrne (Brisbane, Australia)

Association of gait domains with cognitive and neuropsychiatric domains in patients with Parkinson’s disease: A Brazilian exploratory study

E. Lirani-Silva, R. Vitorio, D. Orcioli-Silva, P. Nobrega-Souza, N. Conceição, V. Beretta, L. Gobbi (Portland, OR, USA)

Associations between subjective and objective cognitive decline in Parkinson’s disease

K. Mills, R. Schneider, D. Oaks, M. Saint-Hilaire, R. Hauser, A. Lange, K. Blindauer, M. Halverson, G. Ross, I. Litvan, S. Eberly, T. Simuni, C. Marras (Baltimore, MD, USA)

Baseline Predictors of Constipation and Probable Rapid Eye Movement Sleep Behavior Disorder (pRBD) for Cognitive Impairment After 5 Years of Parkinson’s Disease (PD) Diagnosis in the Parkinson’s Progression Markers Initiative Cohort (PPMI)

W.L Kong, Y. Huang, E. Qian, M. Morris (Sydney, Australia)

Behavioral and Psychological Symptoms in Patients with Movement Disorders

M. Kulsum, S. Anand, H. Kumar (Kolkata,, India)

Both Symptomatic and Asymptomatic Orthostatic Hypotension is Associated with Cognitive Decline Over Time in Parkinson’s Disease

K. Longardner, E. Bayram, I. Litvan (San Diego, CA, USA)

Can clinical outputs predict BDNF levels in people with Parkinson’s disease?

M. Delabary, E. Monteiro, A. Fagundes, M. Casal, A.P Zanardi, F. Boeno, S. Munhoz, R. de Menezes, A. de Oliveira, F. Martinez, L.A Tartaruga, A. Haas (Porto Alegre, Brazil)

Candidate plasma miRNAs and EV protein as novel biomarkers in Parkinson’s disease patients with cognitive impairment and dementia

R.M Wu, Y.Z Tsai, M.C Kuo, Y.u Yoshioka, K.j Ueda, T.k Ochiya, S.P Lin (Taipei, Taiwan)

Cerebral microvascular injury provoked by alpha-synuclein preformed fibrils exacerbates cognitive dysfunction in Parkinson’s disease

Q.X Zhang, Y.Y Gao, L.J Wang (Guangzhou, China)

Cerebrospinal fluid protein markers of cognition in early Parkinson’s disease

I. Markaki, S. Bergström, P. Tsitsi, J. Remnestål, A. Månberg, E. Hertz, W. Paslawski, M. Uhlen, G. Mangone, S. Carvalho, O. Rascol, W. Meissner, E. Magnin, U. Wüllner, J.C Corvol, P. Nilsson, P. Svenningsson (Besancon, France)

Cholinergic basal forebrain atrophy and cognitive decline in advanced Parkinson’s disease

M. Cohn, V. Mutreja, M. Statucka, T. Schmitz (Toronto, ON, Canada)

Clinical outcomes after DBS surgery in cognitively impaired patients with PD

M. Patel, E. Staikova, D. Loring, M. DeLong, S. Triche, C. Esper, T. Wichmann, L. Scorr, L. Higginbotham, P. Aia, S. Factor, C. Buetefisch, S. Miocinovic (Atlanta, GA, USA)

Clinician Ratings of Cognition Predict Trajectory of Cognitive Decline in Newly Diagnosed Individuals with Parkinson’s disease

F. Lopez, E. Trifilio, A. Ratajska, L. Kenney, D. Bowers (Gainesville, FL, USA)

Clock Drawing Test does not Differentiate Alzheimer’s Disease from Parkinson’s Disease Dementia

S. Tezcan Aydemir, M. Kuzu Kumcu, C. Akbostancı (Ankara, Turkey)

Cognitive Fatigue from Attention Cognitive Load in Parkinson’s Disease

s. Chunamchai, P. Jagota, R. Bhidayasiri (Bangkok, Thailand)

Cognitive function and quality of life in Parkinson’s disease: A cross-sectional study

Y.L Tang, X.L Liang, LL. Han, J.T Yu, J. Wang (Shanghai, China)

Cognitive impairment related networks of functional MRI in Parkinson’s disease

W. Sako, T. Abe, Y. Matsumoto, S. Haji, Y. Osaki, M. Harada, Y. Izumi (Tokushima, Japan)

Cognitive profiling of patients with neurodegenerative disorders

I. Zhukova, E. Kolupaeva, N. Zhukova, O. Izhboldina, M. Nikitina, A. Latipova, S. Shtaymets, I. Mironova, Z.h Kislukhina, L. Tkachenko, A. Agasheva, D. Novotnyy (Tomsk, Russian Federation)

Comparative analysis of cognitive function between unilaterally and bilaterally affected Parkinson’s disease

J. Lee, G.S Kim (Goyang-si, Republic of Korea)

Comparison of gait pattern characteristics during Parkinson’s disease progression – Analysis of gait during the dual-task walking

S. Radovanovic, V. Markovic, I. Stankovic, S. Gluscevic, I. Petrovic, V. Kostic (Belgrade, Serbia)

Correlation of brain activity measured using quantitative electroencephalography and cognitive function in patients with de novo Parkinson’s disease

Y.S Kim, S.M Kim, H.W Shin, Y.C Youn, S.W Kang (Seoul, Republic of Korea)

Decreased Regional Cholinergic Signaling in Parkinson’s Disease

J. O'Donnell, Y. Zhou, M. Campbell, S. Mansor, B. Maiti, Z. Tu, J. Perlmutter (Saint Louis, MO, USA)

Deep brain stimulation and cognitive decline in Parkinson’s disease: The predictive value of Alternate Fluency test

R. Ferrucci, F. Mameli, F. Ruggiero, M. Reitano, S. Marceglia, M. Massei, L. Borellini, F. Cogiamanian, T. Bocci, M. Locatelli, S. Barbieri, A. Averna, A. Priori (Milan, Italy)

Diagnostic utility of cerebrospinal fluid t-tau/p-tau181 in Parkinson’s disease with mild cognitive impairment: A cross-sectional study in Chinese cohort

P. Zhang, Y. Li, L.J Wang, Y.H Zhang (Guangzhou, China)

Disentangling postural instability-gait difficulties classification model for the prediction of cognitive impairment in de novo Parkinson’s Disease patients

D. Urso, V. Leta, L. Batzu, T. Yousaf, C. Farrell, D. van Wamelen, R. Chaudhuri (London, United Kingdom)

Do dreams tell the future? Dream content analysis as a predictor of cognitive deterioration in Parkinson’s Disease

P. Bugalho, F. Ladeira, R. Barbosa, J. Marto, C. Borbinha, L. Conceição, M. Saraiva, M. Salavisa, B. Meira, M. Fernandes (Lisboa, Portugal)

Does age at onset of Parkinson’s disease affect the development of dementia?

P. Soliveri, F. Del Sorbo, A. Zecchinelli, G. Sacilotto, N. Meucci, M. Zini, C. Mariani, S. Tesei, G. Pezzoli (Milan, Italy)

Driving in Parkinson’s Disease: A Retrospective Study of Driving and Mobility Assessments

K. Lloyd, D. Gaunt, V. Haunton, R. Skelly, H. Mann, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)

Early cognitive impairment is associated with specific regional cholinergic denervation in Parkinson’s disease

S. vander Zee, J. Boertien, M. Gerritsen, J. Spikman, T. van Laar (Groningen, Netherlands)

Exploring cognitive aspect of linguistic prosody in Parkinson’s disease

A. Basirat, S. Pinto, K. Dujardin, L. Defebvre, D. Devos, C. Moreau (Lille, France)

Exploring the role of the retrograde procedural memory in PD in the Luxembourg Parkinson’s Disease Study

L. Pauly, C. Pauly, G. Hipp, M. Hansen, V. Schröder, R. Krüger (Belvaux, Luxembourg)

Freezing of gait that persists from the OFF to the ON state is associated with memory impairments in Parkinson’s disease

J. McKay, F. Goldstein, B. Sommerfeld, D. Bernhard, S. Factor (Atlanta, GA, USA)

Gender differenes in cognitive functioning in de novo Parkinson’s disease patients

A. Slomp, S. vd Zee, J. Boertien, J. Spikman, T. van Laar (Groningen, Netherlands)

Genetic and environmental prognostics of cognitive trajectories in patients with Parkinson’s disease

S. Jo, K.W Park, S.H Lee, Y.S Hwang, S.J Chung (Seoul, Republic of Korea)

Hand Fine Motor Performance Capacity is Associated with the Cognition in People with Moderate to Advanced Parkinson’s disease

S. Tan, C.T Hong, T.H Liou (New Taipei City, Taiwan)

How Parkinson’s Disease Affects Working Memory

L. Montaser Kouhsari, A. Bakkour, D. Shohamy (New York, NY, USA)

Identification and clinical characteristics of Mild Cognitive Impairment in Parkinson’s disease

J. Yang, E. Forbes, D. Pourzinal, K. McMahon, D. Copland, G. Byrne, J. O'Sullivan, L. Mitchell, N. Dissanayaka (Herston, Australia)

Impact of Obstructive Sleep Apnea on Cognitive and Motor Functions in Parkinson’s Disease Patients

M. Elfil, E. Bahbah, M. Eldokmak, M. Attia, B. Koo (New Haven, CT, USA)

Improved verb use in Parkinson’s disease following intensive voice treatment

A. Ramage, C. Fox, A. Halpern, L. Ramig (Durham, NH, USA)

Increased neurofilament light chain plasma levels as a biological marker of mild cognitive impairment in Parkinson’s disease

J. Pagonabarraga, R. Perez-Gonzalez, H. Bejr-Kasem, J. Marin-Lahoz, A. Horta-Barba, I. Aracil-Bolaños, F. Sampedro, S. Martinez-Horta, J. Perez-Perez, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)

Influence of emotion-affective apathy in theory of mind in Parkinson’s disease patients

O. Lucas-Jiménez, N. Ojeda, J. Peña, I. Gabilondo, A. Murueta-Goyena, J.C Gómez-Esteban, R. del Pino, M. Acera, N. Ibarretxe-Bilbao (Bilbao, Spain)

Information processing components in Parkinson’s disease with and without impulse control disorders: identification of diagnostic and predisposition markers

S.. Cantarero Duque, J.P Romero (Madrid, Spain)

Investigating Factors Contributing to Parkinson’s disease-related Cognitive Decline

P. Tipton, N. Bulbul, J. Crook, O. Ross, Z. Wszolek, N. Ertekin-taner (Jacksonville, FL, USA)

Meynert Nucleus-related Cortical Thinning in Parkinson’s Disease with Mild Cognitive Impairment

S.M Rong, Y. Li, B. Li, K. Nie, P. Zhang, TT. Cai, M.J Mei, L.J Wang, Y.H Zhang (Guangzhou, China)

Modifiable Comorbidities Associated with Rate of Cognitive Decline in Parkinson’s Disease

E. Forbes, T. Tropea, S. Mantri, J. Morley (Philadelphia, PA, USA)

Multimodal EEG-MRI based machine learning model in identifying Parkinson’s disease with mild cognitive impairment

J.H Zhang, L.J Wang, K. Nie (Guangzhou, China)

Neuroprotective propensity of marmelosin against 6-OHDA-induced cognitive impairment and apoptosis via upregulation of PI3K/Akt pathway

E. Yadav (Allahabad, India)

Object and action naming test in cognitive subtypes in nondemented patients with Parkinson´s disease

A. Kušnírová, Z. Košutzká, M. Hajdúk, M. Králová, M. Pápayová, M. Egryová, P. Valkovič, Z. Cséfalvay (Bratislava, Slovakia)

Pareidolias and Cognition in Isolated REM Sleep Behavior Disorder

L. Honeycutt, J.F Gagnon, A. Pelletier, J. De Roy, J. Montplaisir, R. Postuma (Montreal, QC, Canada)

Parkinson’s Disease Clinical Subtypes: Symptom Progression, Dementia, and Mortality

P. Myers, J. Jackson, A. Clover, C. Lessov-Schlaggar, E. Foster, J. Perlmutter, M. Campbell (St. Louis, MO, USA)

Parkinson’s disease patients at Hoehn and Yahr stage 1 show deficits in reactive but not proactive inhibitory control

V. Di Caprio, N. Modugno, C. Mancini, E. Olivola, G. Mirabella (Pozzilli, Italy)

Predicting dementia in the first 6 years of Parkinson’s disease in the ICICLE-PD cohort

R. Lawson, C. William-Gray, M. Camacho, G. Duncan, T. Khoo, D. Breen, R. Barker, L. Rochester, D. Burn, A. Yarnall (Newcastle upon Tyne, United Kingdom)

Predictors of different progressive trajectories of cognition in Parkinson’s disease

G. Smith, R. Zielinski, C. Venuto, M. Javidnia, K. Kieburtz (Rochester, NY, USA)

Premature Cognitive Decline in Young Veterans with mTBI: A Possible Prodromal Signature of Early Stage Parkinson’s Disease

V. Nejtek, M. Salvatore, R. James, H. Alphonso (Fort Worth, TX, USA)

Regional cortical thickness alterations in PD patients with cognitive impairment

V. Goyal, S. Chaudhary, A. Ankeeta, S. Kumaran, P. Bhat (New Delhi, India)

Repetitive transcranial magnetic stimulation (rTMS) fails to improve cognition in patients with Parkinson’s disease: a meta-analysis of randomized controlled trials

P. He, L. Wang, J. Chen, Y. Zhang, Y. Gao, Q. Xu, Y. Qiu, H. Cai, Y. Li, Z. Huang, S. Feng, J. Zhao, G. Ma, K. Nie, L. Wang (Guangzhou, China)

Serum microRNA-29 family as potential biomarkers for cognitive impairment in Parkinson’s disease

Y.L Tang, LL. Han, F. Huang, J. Wang (Shanghai, China)

Short digitalized cognitive test help differentiating Parkinson’s disease (PD) patients with and without Mild Cognitive Impairment (MCI)

J. Montillot, H. Salhi, R. Massart, K. Hernandez, M. Lunven, G. Fénelon, A. Bachoud-Lévi, P. Rémy (Créteil, France)

Subjective Cognitive Complaints in early Parkinson’s Disease patients with normal cognition are associated with affective symptoms

C.Y Chua, M.E Koh, N.Y Chia, S.E Ng, S.E Saffari, M.C Wen, R.Y Chen, X. Choi, D.L Heng, S.X Neo, K.Y Tay, W.L Au, E.K Tan, L.S Tan, Z. Xu (Singapore, Singapore)

Task based profiles of language impairment in Parkinson’s Disease

A. Lowit, M. Roheger, E. Kalbe, T. Thies, J. Steffen, M. Barbe (Glasgow, United Kingdom)

The ‘A’ in the A/T/N Alzheimer’s Disease Biomarker Classification Predicts Cognitive Outcomes in Parkinson’s Disease

N. Han, D. Weintraub, L. Shaw, J. Trojanowski, A. Chen-Plotkin, T. Tropea (Philadelphia, PA, USA)

The dual cognitive syndrome in Parkinson’s disease: volumetric, morphological and tractometric features

Q. Devignes, R. Viard, R. Lopes, N. Betrouni, G. Kuchcinski, G. Carey, L. Defebvre, A. Leentjens, K. Dujardin (Lille, France)

The effect of Deep Brain Stimulation in patients with Parkinson’s Disease on the Brain Cognitive Functions

A. Ivashynka, A. Cucovici (Novara, Italy)

The feasibility of cognitive telerehabilitation in patients with Parkinson´s disease: The pilot data

V. Plzáková (Prague, Czech Republic)

The interplay between asymmetric dopaminergic degeneration, brain structural changes and cognition in de-novo PD: The PPMI dataset

E. Fiorenzato, A. Antonini, W. Weis, P. Bisiacchi, C. Semenza, A. Vallesi, R. Biundo (Venice, Italy)

The relationship between neuromelanin-sensitive MRI, [123I] meta-iodobenzylguanidine scintigraphy and cognition, in patients with Parkinson’s disease

T. Utsunomiya, K. Matsuura, Y. Ii, A. shindo, m. Umino, M. Maeda, H. Tomimoto (Tsu Mie, Japan)

The relationship between REM sleep behavior disorder and cognitive impairment in drug-naïve Parkinson’s disease

A. Karukote, S. Thakolwiboon, P. Julayanont (Lubbock, TX, USA)

The role of attention networks in walking in Parkinson’s disease

R. Drake, G. Eskes (Halifax, NS, Canada)

The role of dementia in Parkinson’s disease

A. Aralbayeva, A. Kondybaeva, S. Kamenova, K. Kuzhibaeva (Almaty, Kazakhstan)

Understanding characteristics, healthcare resource use and costs of patients with Parkinson’s disease prior to and after diagnosis of cognitive impairment

J. Chandler, R. Nair, E. Ferries, L. Munsie, T. Changamire, N. Patel, K. Biglan (Louisville, KY, USA)

Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson’s disease patients with type 2 diabetes mellitus

Q. Wang (Guangzhou, China)

What can tell us Non-Motor Symptoms about Cognition and Gait in the Early Stage of PD Patients

B. Munoz Ospina, V. Quintana-Peña, D. Rincón, J. Valderrama, Y. Castaño-Pino, J. Orozco Velez, A. Navarro (Cali, Colombia)

White Matter Changes and Early Cognitive Impairment in Parkinson’s Disease

T. Belal, S. Elgamal (Mansoura, Egypt)